MwanzoSDZ • SWX
add
Sandoz Group AG
Bei iliyotangulia
CHF 48.25
Bei za siku
CHF 47.55 - CHF 48.25
Bei za mwaka
CHF 26.25 - CHF 50.88
Thamani ya kampuni katika soko
20.97B CHF
Wastani wa hisa zilizouzwa
elfu 831.16
Uwiano wa bei na mapato
116.00
Mgao wa faida
1.25%
Ubadilishanaji wa msingi
SWX
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 2.63B | 4.01% |
Matumizi ya uendeshaji wa biashara | 904.50M | -11.67% |
Mapato halisi | 188.50M | 151.33% |
Kiwango cha faida halisi | 7.16 | 141.89% |
Mapato kwa kila hisa | — | — |
EBITDA | 415.00M | 53.42% |
Asilimia ya kodi ya mapato | 25.20% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.39B | 98.15% |
Jumla ya mali | 21.61B | 11.86% |
Jumla ya dhima | 12.79B | 16.79% |
Jumla ya hisa | 8.82B | — |
hisa zilizosalia | 432.00M | — |
Uwiano wa bei na thamani | 2.36 | — |
Faida inayotokana na mali | 3.48% | — |
Faida inayotokana mtaji | 5.18% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 188.50M | 151.33% |
Pesa kutokana na shughuli | 261.50M | 128.38% |
Pesa kutokana na uwekezaji | -158.00M | 19.80% |
Pesa kutokana na ufadhili | -74.00M | 35.09% |
Mabadiliko halisi ya pesa taslimu | 99.00M | 148.53% |
Mtiririko huru wa pesa | 151.94M | 47.69% |
Kuhusu
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkichen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1886
Tovuti
Wafanyakazi
20,000
